Health News Releases

  • Today May 4
June 25, 2023 13:26
Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)1
Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) today announced additional data demonstrating superior efficacy with survodutide (also known as BI 456906) versus placebo in people with over
Lab work
June 25, 2023 13:20
Artilysin® - A Groundbreaking “Green Pharma” Solution
Lysando, the leading pioneer in the field of antimicrobial proteins has achieved significant milestones with its cutting-edge Artilysin® technology. This innovative platform has demonstrated a distinc
June 25, 2023 10:56
Jardiance® recommended for the treatment of adults with chronic kidney disease in the EU
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Jardiance® (empagliflozin) for the treatment of adults with
Matthew-Shippey-Joins-IPS-as-Managing-Director-APAC (Photo: Business Wire)
June 25, 2023 10:32
IPS Strengthens Asia and Pacific Presence with New Managing Director, Matthew Shippey
IPS, a leading provider of architecture, engineering, procurement, construction management, and validation services, announces the appointment of an industry-leading professional, Matthew Shippey, to
Brainlab, the AO Foundation and Level Ex sign an agreement at the AO Trustees Meeting, June 22 in Sy
June 23, 2023 11:15
Brainlab and the AO Foundation Collaborate on the Future of Immersive Medical Education and Training
Brainlab, a digital medical technology company, announced today an expanded collaboration outlining initiatives in their ongoing work with the AO Foundation. Signed at the annual AO Trustees Meeting—h
Masimo W1™ and Hospital La Fe, Valencia, Spain (Photo: Business Wire)
June 23, 2023 10:41
Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients
Masimo (NASDAQ: MASI) today announced that Hospital La Fe in Valencia, Spain, is expanding its telehealth and telemonitoring program with the Masimo W1™ advanced health tracking watch. Masimo W1, whic
June 22, 2023 14:25
Ferring Pharmaceuticals appoints new Executive Chairman among key changes to Board of Directors
Ferring Pharmaceuticals announced today that Jean-Frédéric Paulsen has been appointed Executive Chairman of the Ferring Group, as it enters a new phase of growth following the approval of two innovati
(Photo: Business Wire)
June 22, 2023 10:55
Ferrer Initiates its ADOREXT Extension Study in Amyotrophic Lateral Sclerosis (ALS)
The international pharmaceutical company Ferrer has announced the extension of its phase III clinical trial ADORE (ALS trial with Daily ORal Edaravone), with FNP122 in amyotrophic lateral sclerosis (A
June 21, 2023 11:30
Takeda Presents Full Data Set from Phase 3 ADVANCE-CIDP 1 Clinical Trial Investigating HYQVIA® as a Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting
Takeda (TSE:4502/NYSE:TAK) today announced full results from the pivotal Phase 3 ADVANCE-CIDP 1 clinical trial investigating HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyalur
June 18, 2023 14:00
Takeda and HUTCHMED Announce Publication of Phase 3 FRESCO-2 Results in The Lancet
Takeda (TSE:4502/NYSE:TAK) and HUTCHMED (China) Limited (Nasdaq/AIM:HCM, HKEX:13) (HUTCHMED) today announced that results of the Phase 3 FRESCO2 study evaluating fruquintinib in patients with previous
June 16, 2023 15:55
SciMed (Asia), Life Science Sales and Service Distributing Subsidiary of PHC Holdings Corporation, Becomes Wholly Owned Subsidiary -- Acquisition Expands PHC Group’s Business Supporting Researchers and Healthcare Providers in Asia-Pacific --
PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has acquired the remaining 30% stake in
June 16, 2023 15:00
Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency
Takeda (TSE:4502/NYSE:TAK) and HUTCHMED (China) Limited (Nasdaq/AIM: HCM, HKEX: 13) (HUTCHMED) today announced that the European Medicines Agency (EMA) has validated and accepted for regulatory review
June 16, 2023 14:16
Ferring Pharmaceuticals successfully increases its second Swiss Franc Bond offering by CHF 80 million
Ad hoc announcement pursuant to Art. 53 LR Ferring Pharmaceuticals announced the successful increase of its second Swiss Franc Bond offering by CHF 80 million. This senior unsecured bond transactio
T cell (orange) interacting with cancer cell (blue) (Graphic: Business Wire)
June 15, 2023 15:38
First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies
With immunotherapy emerging as one of the most important treatment options in oncology, GE HealthCare has today announced the first patient scanned in a Phase I clinical trial[2] of a first-of-its kin
June 14, 2023 14:30
Sound Vaccine Secures KRW 180,000,000,000 Capital Commitment from GEM as Company Seeks to Get Uplisted on KOSDAQ
Sound Vaccine, Inc., (“Sound Vaccine”), a leading manufacturer of advanced hearing medical systems and patented hearing healthcare products, is pleased to announce that it has signed an agreement (“Ag
ZAP-X® Gyroscopic Radiosurgery® platform (Photo: Business Wire)
June 14, 2023 10:40
ZAP Surgical Announces Upcoming Installation of Novel Non-Invasive Brain Tumor Treatment System in South Korea
ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Dankook University Hospital (DKUH) in Cheonan, South Korea, is slated to install the novel ZAP-X
June 13, 2023 15:43
Thales Helps Lunit Accelerate the Growth of AI-based Software Cancer Diagnostic Solutions
Thales, a global leader in Software Monetization and Licensing, is collaborating with Lunit, a global provider of AI-powered cancer diagnostics and therapeutics solutions, to help accelerate the profi
June 13, 2023 14:45
Community Health System Expands Use of Multiple Masimo Technologies, System-wide
Masimo (NASDAQ: MASI) and Community Health System (CHS), based in Fresno, California, today announced that CHS is adopting a variety of advanced Masimo monitoring technologies and solutions across its
June 09, 2023 14:00
Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment
Masimo (NASDAQ: MASI) today announced that the Department of Anesthesiology at the Lausanne University Hospital (CHUV), one of Switzerland’s premier academic institutions, has chosen to make the Masim
June 09, 2023 10:50
Parse Biosciences Launches CRISPR Detect
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unpreceden
June 08, 2023 15:30
Chef Marcus Samuelsson Invests in Aleph Farms, Plans to Serve Aleph Cuts Cultivated Steaks
Aleph Farms, a cellular agriculture company designing new ways to grow quality animal products, today announced that Chef Marcus Samuelsson is joining the company as an investor, culinary advisor and
June 08, 2023 14:30
Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health
Today, Organon (NYSE:OGN), a global healthcare company focused on women’s health, and CAF, Development Bank of Latin America, signed a memorandum of understanding (MOU) to contribute to the United Nat
June 08, 2023 11:50
Kenvue to Announce Second Quarter 2023 Results on July 20, 2023
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced that its financial results for the second quarter ending July 2, 2023, will be re
June 08, 2023 08:30
CORELINE SOFT Participates in ACTI 2023... Asian Medical AI Experts Invited as Speakers
SEOUL - Coreline Soft (CEO Jinkook Kim, Jungpill Choi), a company specializing in medical artificial intelligence (AI), participates in the ‘5th Asian Society of Thoracic Radiology & 22nd Korean Socie
June 07, 2023 16:20
MRM Health Appoints Katja Conrath as Chief Scientific Officer
MRM Health - a clinical-stage biopharmaceutical company focused on developing innovative microbiome-based biotherapeutics based on its proprietary and unique CORAL® platform technology - today announc
25 per page50 per page75 per page100 per page